首页 | 本学科首页   官方微博 | 高级检索  
检索        

冠脉介入治疗术中应用国产替罗非班临床观察
引用本文:吕云,卢竞前,李易,李建美,洪云飞,杨锋.冠脉介入治疗术中应用国产替罗非班临床观察[J].中国现代医生,2008,46(6):44-45.
作者姓名:吕云  卢竞前  李易  李建美  洪云飞  杨锋
作者单位:云南省红十字会医院心脏中心内科,昆明,650021
摘    要:目的观察国产替罗非班在冠状动脉介入治疗术治疗急性冠脉综合征中的临床应用。方法59例ACS患者PCI术中应用国产替罗非班,与同期常规PCI术治疗的患者相比,评价国产替罗非班在ACS中的效果。结果PCI术中出现慢血流或无血流现象应用国产替罗非班38例,血流明显改善29例。国产替罗非班组出血2例。结论国产替罗非班对改善冠脉PCI术慢血流、无再流有明显作用,能预防术后血栓形成,值得深入研究。

关 键 词:急性冠脉综合征  冠状动脉介入治疗  国产替罗非班

Clinical Observation of Tirofiban in PCI Operation
Authors:LV Yun  LU Jingqian  LI Yi  LI Jianmei  HONG Yunfei  YANG Feng
Institution:(The Cardiology Department of Heart Center, Red Cross Hospital of Yunnan, Kunming 650021)
Abstract:Objective To observe the effect of Tirofiban made in China during PCI operation in ACS patients. Methods Fifty-nine ACS patients used Tirofiban during PCI operation, compared with the routine group, and we evaluated effect of Tirofiban in ACS. Results Thirty-eight patients used Tirofiban during PCI operation. Twenty-nine patients had improved TIMI flow. Two patients had bleed in Tirofiban group. Conclusion Tirofiban made in china can improve TIMI flow significantly and prevent thrombosis, it is worthy for more research.
Keywords:Acute coronary syndrome  Percutaneous coronary intervention  Tirofiban made in China
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号